Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection

Cancers
Thilo GambichlerJ C Becker

Abstract

Whether cancer patients receiving immune checkpoint inhibitors (ICI) are at an increased risk of severe infection and mortality during the corona pandemic is a hotly debated topic that will continue to evolve. Here, we summarize and discuss current studies regarding COVID-19 and anti-cancer treatment with an emphasis on ICI. Importantly, several lines of evidence suggest that patients currently treated with ICI do not display an increased vulnerability to infection with SARS-CoV-2. Data regarding morbidity and mortality associated with COVID-19 in cancer patients receiving ICI are less clear and often conflicting. Although mostly based on experimental data, it is possible that ICI can promote the exacerbated immune response associated with adverse outcome in COVID-19 patients. On the other hand, mounting evidence suggests that ICI might even be useful in the treatment of viral infections by preventing or ameliorating T cell exhaustion. In this context, the right timing of treatment might be essential. Nevertheless, some cancer patients treated with ICI experience autoimmune-related side effects that require the use of immunosuppressive therapies, which in turn may promote a severe course of infection with SARS-CoV-2. Although t...Continue Reading

References

Oct 22, 2010·Allergology International : Official Journal of the Japanese Society of Allergology·Tetsuo ShioharaYoko Kano
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Feb 28, 2017·Cancer·Douglas B JohnsonAlexander M Menzies
Apr 11, 2017·European Journal of Immunology·Lydia Dyck, Kingston H G Mills
May 26, 2017·Pediatric Blood & Cancer·Seth J RotzJoseph G Pressey
Sep 26, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L KhojaA R Hansen
Oct 11, 2017·Nature Reviews. Immunology·Michelle N Wykes, Sharon R Lewin
Feb 8, 2018·Annual Review of Medicine·Masao HashimotoRafi Ahmed
Apr 11, 2018·Cancer Cell·Roberta ZappasodiJedd D Wolchok
Sep 30, 2018·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Karthik SureshJarushka Naidoo
Dec 14, 2018·Experimental & Molecular Medicine·Pramod DarvinEyad Elkord
Mar 30, 2019·Journal for Immunotherapy of Cancer·Christine Ménétrier-CauxChristophe Caux
Nov 7, 2019·Molecular Cancer·Shuang QinSuxia Luo
Feb 19, 2020·The Lancet Oncology·Wenhua LiangJianxing He
Mar 27, 2020·Asia-Pacific Journal of Clinical Oncology·Anqi WangMengzhao Wang
Mar 29, 2020·BMJ : British Medical Journal·Rachel E JordanK K Cheng
Apr 1, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L ZhangM Zhou
Apr 2, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Changcheng ZhengUNKNOWN Anhui Medical team members of National aid to prevent and treat novel coronavirus pneumonia in Wuhan
Apr 4, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lucia BonomiAnna Cecilia Bettini
Apr 16, 2020·The Journal of Allergy and Clinical Immunology·Xiaochen LiJianping Zhao
Apr 18, 2020·Journal for Immunotherapy of Cancer·Paolo Antonio AsciertoJeffrey S Weber
Apr 21, 2020·Bioinformation·Francesco ChiappelliGillian Greenberg
Apr 24, 2020·Future Oncology·Elie RassyJoseph Kattan
Apr 25, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H MiyashitaC Cruz
Apr 29, 2020·Critical Reviews in Oncology/hematology·Elissar MoujaessMarwan Ghosn
May 1, 2020·Immunotherapy·Alexander P DavisSteven C Kao
May 1, 2020·The Journal of Experimental Medicine·Santosha A Vardhana, Jedd D Wolchok
May 14, 2020·International Journal of Molecular Sciences·Andrea Picchianti DiamantiBruno Laganà

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
PCR

Clinical Trials Mentioned

NCT03999749
NCT04335305
NCT04413838
NCT04343144
NCT04356508

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.